Mohd Haniff Nurin Syazwina, Ng Kwan Hoong, Kamal Izdihar, Mohd Zain Norhayati, Abdul Karim Muhammad Khalis
Department of Physics, Faculty of Science, Universiti Putra Malaysia, UPM, 43400 Serdang, Selangor, Malaysia.
Department of Biomedical Imaging, Universiti Malaya, 50603 Kuala Lumpur, Malaysia.
Heliyon. 2024 Aug 14;10(16):e36313. doi: 10.1016/j.heliyon.2024.e36313. eCollection 2024 Aug 30.
The aim of this systematic review and meta-analysis is to evaluate the performance of classification metrics of machine learning-driven radiomics in diagnosing hepatocellular carcinoma (HCC). Following the PRISMA guidelines, a comprehensive search was conducted across three major scientific databases-PubMed, ScienceDirect, and Scopus-from 2018 to 2022. The search yielded a total of 436 articles pertinent to the application of machine learning and deep learning for HCC prediction. These studies collectively reflect the burgeoning interest and rapid advancements in employing artificial intelligence (AI)-driven radiomics for enhanced HCC diagnostic capabilities. After the screening process, 34 of these articles were chosen for the study. The area under curve (AUC), accuracy, specificity, and sensitivity of the proposed and basic models were assessed in each of the studies. Jamovi (version 1.1.9.0) was utilised to carry out a meta-analysis of 12 cohort studies to evaluate the classification accuracy rate. The risk of bias was estimated, and Logistic Regression was found to be the most suitable classifier for binary problems, with least absolute shrinkage and selection operator (LASSO) as the feature selector. The pooled proportion for HCC prediction classification was high for all performance metrics, with an AUC value of 0.86 (95 % CI: 0.83-0.88), accuracy of 0.83 (95 % CI: 0.78-0.88), sensitivity of 0.80 (95 % CI: 0.75-0.84) and specificity of 0.84 (95 % CI: 0.80-0.88). The performance of feature selectors, classifiers, and input features in detecting HCC and related factors was evaluated and it was observed that radiomics features extracted from medical images were adequate for AI to accurately distinguish the condition. HCC based radiomics has favourable predictive performance especially with addition of clinical features that may serve as tool that support clinical decision-making.
本系统评价和荟萃分析的目的是评估机器学习驱动的放射组学分类指标在诊断肝细胞癌(HCC)中的性能。按照PRISMA指南,于2018年至2022年在三个主要科学数据库——PubMed、ScienceDirect和Scopus中进行了全面检索。检索共获得436篇与机器学习和深度学习在HCC预测中的应用相关的文章。这些研究共同反映了人们对采用人工智能(AI)驱动的放射组学来增强HCC诊断能力的兴趣日益浓厚以及快速进展。经过筛选过程,选择了其中34篇文章进行研究。在每项研究中评估了所提出模型和基本模型的曲线下面积(AUC)、准确性、特异性和敏感性。利用Jamovi(版本1.1.9.0)对12项队列研究进行荟萃分析,以评估分类准确率。估计了偏倚风险,发现逻辑回归是二元问题最合适的分类器,以最小绝对收缩和选择算子(LASSO)作为特征选择器。所有性能指标的HCC预测分类合并比例都很高,AUC值为0.86(95%CI:0.83 - 0.88),准确性为0.83(95%CI:0.78 - 0.88),敏感性为0.80(95%CI:0.75 - 0.84),特异性为0.84(95%CI:0.80 - 0.88)。评估了特征选择器、分类器和输入特征在检测HCC及相关因素方面的性能,观察到从医学图像中提取的放射组学特征足以让AI准确区分病情。基于HCC的放射组学具有良好的预测性能,特别是在添加可能作为支持临床决策工具的临床特征时。